Leptin as regulator of pulmonary immune responses: Involvement in respiratory diseases

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 4, 2013, Pages 464-472

  Vernooy, Juanita H J ^a   Ubags, Niki D J ^a,b   Brusselle, Guy G ^c   Tavernier, Jan ^d   Suratt, Benjamin T ^b   Joos, Guy F ^c   Wouters, Emiel F M ^a   Bracke, Ken R ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Asthma; COPD; Leptin; Pneumonia; Pulmonary immunity

Indexed keywords

8 ISOPROSTANE; CIGARETTE SMOKE; LEPTIN; LEPTIN RECEPTOR; LUNG SURFACTANT;

APOPTOSIS; ARTICLE; ASTHMA; BACTERIAL INFECTION; BODY WEIGHT; BREATHING; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; EOSINOPHIL; EXERCISE; FETUS LUNG; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG DEVELOPMENT; LUNG FUNCTION; LUNG INFECTION; LUNG PARENCHYMA; NEGATIVE FEEDBACK; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OBESITY; PATHOGENESIS; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SIGNAL TRANSDUCTION; SMOKING; SMOKING CESSATION; T LYMPHOCYTE; TH1 CELL; VIRUS INFECTION; XENOPUS LAEVIS;

ADAPTIVE IMMUNITY; ANIMALS; ASTHMA; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LEPTIN; LUNG; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84880507391     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.03.016     Document Type: Article

References (143)

1. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
2. Wauman J., Tavernier J. Leptin receptor signaling: pathways to leptin resistance. Front Biosci 2011, 17:2771-2793.
3. Otero M., Lago R., Gomez R., Dieguez C., Lago F., Gomez-Reino J., et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 2006, 45:944-950.
4. Masuzaki H., Ogawa Y., Sagawa N., Hosoda K., Matsumoto T., Mise H., et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997, 3:1029-1033.
5. Mix H., Widjaja A., Jandl O., Cornberg M., Kaul A., Goke M., et al. Expression of leptin and leptin receptor isoforms in the human stomach. Gut 2000, 47:481-486.
6. Sitaraman S., Liu X., Charrier L., Gu L.H., Ziegler T.R., Gewirtz A., et al. Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. Faseb J 2004, 18:696-698.
7. Smith-Kirwin S.M., O'Connor D.M., De Johnston J., Lancey E.D., Hassink S.G., Funanage V.L. Leptin expression in human mammary epithelial cells and breast milk. JClin Endocrinol Metab 1998, 83:1810-1813.
8. Morash B., Li A., Murphy P.R., Wilkinson M., Ur E. Leptin gene expression in the brain and pituitary gland. Endocrinology 1999, 140:5995-5998.
9. Wang J., Liu R., Hawkins M., Barzilai N., Rossetti L. Anutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 1998, 393:684-688.
10. Wang J., Liu R., Liu L., Chowdhury R., Barzilai N., Tan J., et al. The effect of leptin on lep expression is tissue-specific and nutritionally regulated. Nat Med 1999, 5:895-899.
11. Reseland J.E., Syversen U., Bakke I., Qvigstad G., Eide L.G., Hjertner O., et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. JBone Miner Res 2001, 16:1426-1433.
12. Laharrague P., Larrouy D., Fontanilles A.M., Truel N., Campfield A., Tenenbaum R., et al. High expression of leptin by human bone marrow adipocytes in primary culture. Faseb J 1998, 12:747-752.
13. Vernooy J.H., Drummen N.E., van Suylen R.J., Cloots R.H., Moller G.M., Bracke K.R., et al. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Thorax 2009, 64:26-32.
14. Henson M.C., Swan K.F., Edwards D.E., Hoyle G.W., Purcell J., Castracane V.D. Leptin receptor expression in fetal lung increases in late gestation in the baboon: a model for human pregnancy. Reproduction 2004, 127:87-94.
15. Vernooy J.H., Bracke K.R., Drummen N.E., Pauwels N.S., Zabeau L., van Suylen R.J., et al. Leptin modulates innate and adaptive immune cell recruitment after cigarette smoke exposure in mice. JImmunol 2010, 184:7169-7177.
16. Hammond J.A., Bennett K.A., Walton M.J., Hall A.J. Molecular cloning and expression of leptin in gray and harbor seal blubber, bone marrow, and lung and its potential role in marine mammal respiratory physiology. Am J Physiol Regul Integr Comp Physiol 2005, 289:R545-R553.
17. Torday J.S., Ihida-Stansbury K., Rehan V.K. Leptin stimulates Xenopus lung development: evolution in a dish. Evol Dev 2009, 11:219-224.
18. Bruno A., Chanez P., Chiappara G., Siena L., Giammanco S., Gjomarkaj M., et al. Does leptin play a cytokine-like role within the airways of COPD patients?. Eur Respir J 2005, 26:398-405.
19. Torday J.S., Sun H., Wang L., Torres E., Sunday M.E., Rubin L.P. Leptin mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation. Am J Physiol Lung Cell Mol Physiol 2002, 282:L405-L410.
20. Wabitsch M., Jensen P.B., Blum W.F., Christoffersen C.T., Englaro P., Heinze E., et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996, 45:1435-1438.
21. Machinal F., Dieudonne M.N., Leneveu M.C., Pecquery R., Giudicelli Y. Invivo and invitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology 1999, 140:1567-1574.
22. Mattsson C., Olsson T. Estrogens and glucocorticoid hormones in adipose tissue metabolism. Curr Med Chem 2007, 14:2918-2924.
23. De Pergola G. The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int J Obes Relat Metab Disord 2000, 24(Suppl. 2):S59-S63.
24. Sarraf P., Frederich R.C., Turner E.M., Ma G., Jaskowiak N.T., Rivet D.J., et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. JExp Med 1997, 185:171-175.
25. Gualillo O., Eiras S., Lago F., Dieguez C., Casanueva F.F. Elevated serum leptin concentrations induced by experimental acute inflammation. Life Sci 2000, 67:2433-2441.
26. Popa C., Netea M.G., Radstake T.R., van Riel P.L., Barrera P., van der Meer J.W. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis 2005, 64:1195-1198.
27. Zhang H.H., Kumar S., Barnett A.H., Eggo M.C. Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol 2000, 159:79-88.
28. Lollmann B., Gruninger S., Stricker-Krongrad A., Chiesi M. Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem Biophys Res Commun 1997, 238:648-652.
29. Tsuchiya T., Shimizu H., Horie T., Mori M. Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol 1999, 365:273-279.
30. Dal Farra C., Zsurger N., Vincent J.P., Cupo A. Binding of a pure 125I-monoiodoleptin analog to mouse tissues: a developmental study. Peptides 2000, 21:577-587.
31. Bergen H.T., Cherlet T.C., Manuel P., Scott J.E. Identification of leptin receptors in lung and isolated fetal type II cells. Am J Respir Cell Mol Biol 2002, 27:71-77.
32. Bellmeyer A., Martino J.M., Chandel N.S., Scott Budinger G.R., Dean D.A., Mutlu G.M. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2007, 175:587-594.
33. Broekhuizen R., Vernooy J.H., Schols A.M., Dentener M.A., Wouters E.F. Leptin as local inflammatory marker in COPD. Respir Med 2005, 99:70-74.
34. Carpagnano G.E., Spanevello A., Curci C., Salerno F., Palladino G.P., Resta O., et al. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients. Oncol Res 2007, 16:375-381.
35. Bruno A., Alessi M., Soresi S., Bonanno A., Riccobono L., Montalbano A.M., et al. Increased leptin/leptin receptor pathway affects systemic and airway inflammation in COPD former smokers. JInflamm Res 2011, 4:51-59.
36. Holguin F., Rojas M., Brown L.A., Fitzpatrick A.M. Airway and plasma leptin and adiponectin in lean and obese asthmatics and controls. JAsthma 2011, 48:217-223.
37. Jain M., Budinger G.R., Lo A., Urich D., Rivera S.E., Ghosh A.K., et al. Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-gamma. Am J Respir Crit Care Med 2011, 183:1490-1498.
38. Tartaglia L.A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995, 83:1263-1271.
39. Tartaglia L.A. The leptin receptor. JBiol Chem 1997, 272:6093-6096.
40. Myers M.G. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 2004, 59:287-304.
41. Wauman J., De Ceuninck L., Vanderroost N., Lievens S., Tavernier J. RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding. JCell Sci 2011, 124:921-932.
42. Uotani S., Bjorbaek C., Tornoe J., Flier J.S. Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation. Diabetes 1999, 48:279-286.
43. Bjorbak C., Lavery H.J., Bates S.H., Olson R.K., Davis S.M., Flier J.S., et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. JBiol Chem 2000, 275:40649-40657.
44. Munzberg H., Myers M.G. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005, 8:566-570.
45. Cook W.S., Unger R.H. Protein tyrosine phosphatase 1B: a potential leptin resistance factor of obesity. Dev Cell 2002, 2:385-387.
46. Zabolotny J.M., Bence-Hanulec K.K., Stricker-Krongrad A., Haj F., Wang Y., Minokoshi Y., et al. PTP1B regulates leptin signal transduction invivo. Dev Cell 2002, 2:489-495.
47. Huang K., Rabold R., Abston E., Schofield B., Misra V., Galdzicka E., et al. Effects of leptin deficiency on postnatal lung development in mice. JAppl Physiol 2008, 105:249-259.
48. Kirwin S.M., Bhandari V., Dimatteo D., Barone C., Johnson L., Paul S., et al. Leptin enhances lung maturity in the fetal rat. Pediatr Res 2006, 60:200-204.
49. Gnanalingham M.G., Mostyn A., Webb R., Keisler D.H., Raver N., Alves-Guerra M.C., et al. Differential effects of leptin administration on the abundance of UCP2 and glucocorticoid action during neonatal development. Am J Physiol Endocrinol Metab 2005, 289:E1093-E1100.
50. Sato A., Schehr A., Ikegami M. Leptin does not influence surfactant synthesis in fetal sheep and mice lungs. Am J Physiol Lung Cell Mol Physiol 2011, 300:L498-L505.
51. Gnanalingham M.G., Mostyn A., Dandrea J., Yakubu D.P., Symonds M.E., Stephenson T. Ontogeny and nutritional programming of uncoupling protein-2 and glucocorticoid receptor mRNA in the ovine lung. JPhysiol 2005, 565:159-169.
52. Pecqueur C., Alves-Guerra M.C., Gelly C., Levi-Meyrueis C., Couplan E., Collins S., et al. Uncoupling protein 2, invivo distribution, induction upon oxidative stress, and evidence for translational regulation. JBiol Chem 2001, 276:8705-8712.
53. Tankersley C.G., O'Donnell C., Daood M.J., Watchko J.F., Mitzner W., Schwartz A., et al. Leptin attenuates respiratory complications associated with the obese phenotype. JAppl Physiol 1998, 85:2261-2269.
54. O'Donnell C.P., Schaub C.D., Haines A.S., Berkowitz D.E., Tankersley C.G., Schwartz A.R., et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 1999, 159:1477-1484.
55. La Cava A., Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004, 4:371-379.
56. Caldefie-Chezet F., Poulin A., Vasson M.P. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic Res 2003, 37:809-814.
57. Moore S.I., Huffnagle G.B., Chen G.H., White E.S., Mancuso P. Leptin modulates neutrophil phagocytosis of Klebsiella pneumoniae. Infect Immun 2003, 71:4182-4185.
58. Loffreda S., Yang S.Q., Lin H.Z., Karp C.L., Brengman M.L., Wang D.J., et al. Leptin regulates proinflammatory immune responses. Faseb J 1998, 12:57-65.
59. Santos-Alvarez J., Goberna R., Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999, 194:6-11.
60. Kordonowy L.L., Burg E., Lenox C.C., Gauthier L.M., Petty J.M., Antkowiak M., et al. Obesity is associated with neutrophil dysfunction and attenuation of murine acute lung injury. Am J Respir Cell Mol Biol 2012, 47:120-127.
61. Martin-Romero C., Santos-Alvarez J., Goberna R., Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000, 199:15-24.
62. Fujita Y., Murakami M., Ogawa Y., Masuzaki H., Tanaka M., Ozaki S., et al. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol 2002, 128:21-26.
63. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394:897-901.
64. Wouters E.F. COPD: from an organ- to a disease-oriented approach. Copd 2008, 5:73-74.
65. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
66. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
67. Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003, 107:1514-1519.
68. Schols A.M., Creutzberg E.C., Buurman W.A., Campfield L.A., Saris W.H., Wouters E.F. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:1220-1226.
69. Takabatake N., Nakamura H., Abe S., Hino T., Saito H., Yuki H., et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:1215-1219.
70. Yang Y.M., Sun T.Y., Liu X.M. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients. Chin Med J (Engl) 2006, 119:628-633.
71. Breyer M.K., Rutten E.P., Vernooy J.H., Spruit M.A., Dentener M.A., van der Kallen C., et al. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med 2011, 105:1046-1053.
72. Breyer M.K., Rutten E.P., Locantore N.W., Watkins M.L., Miller B.E., Wouters E.F. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease. Eur J Clin Invest 2012, 42:983-991.
73. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. NEngl J Med 2004, 350:1005-1012.
74. Gaki E., Kontogianni K., Papaioannou A.I., Bakakos P., Gourgoulianis K.I., Kostikas K., et al. Associations between BODE index and systemic inflammatory biomarkers in COPD. COPD 2011, 8:408-413.
75. Hogg J.C. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004, 364:709-721.
76. Hansel N.N., Gao L., Rafaels N.M., Mathias R.A., Neptune E.R., Tankersley C., et al. Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J Off J Eur Soc Clin Respir Physiol 2009, 34:103-110.
77. Ye X.W., Xiao M., Ye J., Zhang X.Y., Xiao J., Feng Y.L., et al. The polymorphism -2548G/A in leptin and severity of chronic obstructive pulmonary disease. Int J Immunogenet 2011, 38:45-50.
78. Hoffstedt J., Eriksson P., Mottagui-Tabar S., Arner P. Apolymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002, 34:355-359.
79. Woo H.J., Yoo W.J., Bae C.H., Song S.Y., Kim Y.W., Park S.Y., et al. Leptin up-regulates MUC5B expression in human airway epithelial cells via mitogen-activated protein kinase pathway. Exp Lung Res 2010, 36:262-269.
80. Vernooy J.H.J., Haegens A., Van Opbergen D., Cloots R.H.E., Wouters E.F.M. Leptin activates the JAK/STAT signaling pathway in bronchial and alveolar epithelial cells. Eur Respir J 2006, 28(Suppl. 50):S338.
81. Holgate S.T. Pathophysiology of asthma: what has our current understanding taught us about new therapeutic approaches?. JAllergy Clin Immunol 2011, 128:495-505.
82. Larche M. Regulatory T cells in allergy and asthma. Chest 2007, 132:1007-1014.
83. Ford E.S. The epidemiology of obesity and asthma. JAllergy Clin Immunol 2005, 115:897-909.
84. Taylor B., Mannino D., Brown C., Crocker D., Twum-Baah N., Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008, 63:14-20.
85. Camargo C.A., Weiss S.T., Zhang S., Willett W.C., Speizer F.E. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999, 159:2582-2588.
86. Castro-Rodriguez J.A., Holberg C.J., Morgan W.J., Wright A.L., Martinez F.D. Increased incidence of asthmalike symptoms in girls who become overweight or obese during the school years. Am J Respir Crit Care Med 2001, 163:1344-1349.
87. Ronmark E., Andersson C., Nystrom L., Forsberg B., Jarvholm B., Lundback B. Obesity increases the risk of incident asthma among adults. Eur Respir J 2005, 25:282-288.
88. Lavoie K.L., Bacon S.L., Labrecque M., Cartier A., Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006, 100:648-657.
89. Saint-Pierre P., Bourdin A., Chanez P., Daures J.P., Godard P. Are overweight asthmatics more difficult to control?. Allergy 2006, 61:79-84.
90. Shore S.A. Obesity and asthma: possible mechanisms. JAllergy Clin Immunol 2008, 121:1087-1093.
91. Hallstrand T.S., Fischer M.E., Wurfel M.M., Afari N., Buchwald D., Goldberg J. Genetic pleiotropy between asthma and obesity in a community-based sample of twins. JAllergy Clin Immunol 2005, 116:1235-1241.
92. Biring M.S., Lewis M.I., Liu J.T., Mohsenifar Z. Pulmonary physiologic changes of morbid obesity. Am J Med Sci 1999, 318:293-297.
93. Sulit L.G., Storfer-Isser A., Rosen C.L., Kirchner H.L., Redline S. Associations of obesity, sleep-disordered breathing, and wheezing in children. Am J Respir Crit Care Med 2005, 171:659-664.
94. Fantuzzi G. Adipose tissue, adipokines, and inflammation. JAllergy Clin Immunol 2005, 115:911-919.
95. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005, 96:939-949.
96. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
97. Shore S.A., Schwartzman I.N., Mellema M.S., Flynt L., Imrich A., Johnston R.A. Effect of leptin on allergic airway responses in mice. JAllergy Clin Immunol 2005, 115:103-109.
98. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008, 8:183-192.
99. Shore S.A., Rivera-Sanchez Y.M., Schwartzman I.N., Johnston R.A. Responses to ozone are increased in obese mice. JAppl Physiol 2003, 95:938-945.
100. Williams A.S., Leung S.Y., Nath P., Khorasani N.M., Bhavsar P., Issa R., et al. Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. JAppl Physiol 2007, 103:1189-1195.
101. Lu F.L., Johnston R.A., Flynt L., Theman T.A., Terry R.D., Schwartzman I.N., et al. Increased pulmonary responses to acute ozone exposure in obese db/db mice. Am J Physiol Lung Cell Mol Physiol 2006, 290:L856-L865.
102. Johnston R.A., Theman T.A., Lu F.L., Terry R.D., Williams E.S., Shore S.A. Diet-induced obesity causes innate airway hyperresponsiveness to methacholine and enhances ozone-induced pulmonary inflammation. JAppl Physiol 2008, 104:1727-1735.
103. Guler N., Kirerleri E., Ones U., Tamay Z., Salmayenli N., Darendeliler F. Leptin: does it have any role in childhood asthma?. JAllergy Clin Immunol 2004, 114:254-259.
104. Sood A., Ford E.S., Camargo C.A. Association between leptin and asthma in adults. Thorax 2006, 61:300-305.
105. Jartti T., Saarikoski L., Jartti L., Lisinen I., Jula A., Huupponen R., et al. Obesity, adipokines and asthma. Allergy 2009, 64:770-777.
106. Erel F., Gulec M., Kartal O., Caliskaner Z., Ozturk S., Yaman H., et al. Serum leptin levels and lipid profiles in patients with allergic rhinitis and mild asthma. Allergol Immunopathol (Madr) 2007, 35:232-238.
107. Jang A.S., Kim T.H., Park J.S., Kim K.U., Uh S.T., Seo K.H., et al. Association of serum leptin and adiponectin with obesity in asthmatics. JAsthma 2009, 46:59-63.
108. Bruno A., Pace E., Chanez P., Gras D., Vachier I., Chiappara G., et al. Leptin and leptin receptor expression in asthma. JAllergy Clin Immunol 2009, 124:230-237. 7 e1-4.
109. Holguin F., Rojas M., Hart C.M. The peroxisome proliferator activated receptor gamma (PPARgamma) ligand rosiglitazone modulates bronchoalveolar lavage levels of leptin, adiponectin, and inflammatory cytokines in lean and obese mice. Lung 2007, 185:367-372.
110. Lugogo N.L., Hollingsworth J.W., Howell D.L., Que L.G., Francisco D., Church T.D., et al. Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am J Respir Crit Care Med 2012, 186:404-411.
111. Lessard A., St-Laurent J., Turcotte H., Boulet L.P. Leptin and adiponectin in obese and non-obese subjects with asthma. Biomarkers 2011, 16:271-273.
112. Holguin F., Rojas M., Brown L.A., Fitzpatrick A.M. Airway and plasma leptin and adiponectin in lean and obese asthmatics and controls. JAsthma Off J Assoc Care Asthma 2011, 48:217-223.
113. Conus S., Bruno A., Simon H.U. Leptin is an eosinophil survival factor. JAllergy Clin Immunol 2005, 116:1228-1234.
114. Kato H., Ueki S., Kamada R., Kihara J., Yamauchi Y., Suzuki T., et al. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Int Arch Allergy Immunol 2011, 155:335-344.
115. Wong C.K., Cheung P.F., Lam C.W. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Eur J Immunol 2007, 37:2337-2348.
116. Takeda M., Ueki S., Kato H., Konno Y., Chihara M., Itoga M., et al. Obesity and eosinophilic inflammation: does leptin play a role. Int Arch Allergy Immunol 2012, 158(Suppl. 1):87-91.
117. Lintomen L., Calixto M.C., Schenka A., Antunes E. Allergen-induced bone marrow eosinophilopoiesis and airways eosinophilic inflammation in leptin-deficient ob/ob mice. Obesity (Silver Spring) 2012, 20:1959-1965.
118. Piitulainen E., Areberg J., Linden M., Eriksson S., Mattsson S., Wollmer P. Nutritional status and muscle strength in patients with emphysema and severe alpha(1)-antitrypsin deficiency. Chest 2002, 122:1240-1246.
119. Schattner M. Enteral nutritional support of the patient with cancer: route and role. JClin Gastroenterol 2003, 36:297-302.
120. Jedrychowski W., Maugeri U., Flak E., Mroz E., Bianchi I. Predisposition to acute respiratory infections among overweight preadolescent children: an epidemiologic study in Poland. Public Health 1998, 112:189-195.
121. LaCroix A.Z., Lipson S., Miles T.P., White L. Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep 1989, 104:350-360.
122. Baik I., Curhan G.C., Rimm E.B., Bendich A., Willett W.C., Fawzi W.W. Aprospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000, 160:3082-3088.
123. Van Kerkhove M.D., Vandemaele K.A., Shinde V., Jaramillo-Gutierrez G., Koukounari A., Donnelly C.A., et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011, 8:e1001053.
124. Kwong J.C., Campitelli M.A., Rosella L.C. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011, 53:413-421.
125. Mancuso P., Gottschalk A., Phare S.M., Peters-Golden M., Lukacs N.W., Huffnagle G.B. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. JImmunol 2002, 168:4018-4024.
126. Hsu A., Aronoff D.M., Phipps J., Goel D., Mancuso P. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin Exp Immunol 2007, 150:332-339.
127. Ordway D., Henao-Tamayo M., Smith E., Shanley C., Harton M., Troudt J., et al. Animal model of Mycobacterium abscessus lung infection. JLeukoc Biol 2008, 83:1502-1511.
128. Cederholm T., Lindgren J.A., Palmblad J. Impaired leukotriene C4 generation in granulocytes from protein-energy malnourished chronically ill elderly. JIntern Med 2000, 247:715-722.
129. Jubiz W., Draper R.E., Gale J., Nolan G. Decreased leukotriene B4 synthesis by polymorphonuclear leukocytes from male patients with diabetes mellitus. Prostaglandins Leukot Med 1984, 14:305-311.
130. Ubags N., Vernooy J.H., Burg E., Nick J.A., Abraham E., Tavernier J., et al. Obesity and the role of leptin in human and murine acute lung injury/ARDS. Am J Respir Crit Care Med May 2012, 185:A4112.
131. Mancuso P., Huffnagle G.B., Olszewski M.A., Phipps J., Peters-Golden M. Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am J Respir Crit Care Med 2006, 173:212-218.
132. Mancuso P., Peters-Golden M., Goel D., Goldberg J., Brock T.G., Greenwald-Yarnell M., et al. Disruption of leptin receptor-STAT3 signaling enhances leukotriene production and pulmonary host defense against pneumococcal pneumonia. JImmunol 2011, 186:1081-1090.
133. Mancuso P., Myers M.G., Goel D., Serezani C.H., O'Brien E., Goldberg J., et al. Ablation of leptin receptor-mediated ERK activation impairs host defense against gram-negative pneumonia. JImmunol 2012, 189:867-875.
134. Wieland C.W., Stegenga M.E., Florquin S., Fantuzzi G., van der P.T. Leptin and host defense against gram-positive and gram-negative pneumonia in mice. Shock 2006, 25:414-419.
135. Wieland C.W., Florquin S., Chan E.D., Leemans J.C., Weijer S., Verbon A., et al. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice. Int Immunol 2005, 17:1399-1408.
136. Lemos M.P., Rhee K.Y., McKinney J.D. Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression. JImmunol 2011, 187:3776-3784.
137. Smith A.G., Sheridan P.A., Harp J.B., Beck M.A. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. JNutr 2007, 137:1236-1243.
138. Easterbrook J.D., Dunfee R.L., Schwartzman L.M., Jagger B.W., Sandouk A., Kash J.C., et al. Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus. Influenza Other Respi Virus 2011, 5:418-425.
139. Lin S., Thomas T.C., Storlien L.H., Huang X.F. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 2000, 24:639-646.
140. Zhang A.J., To K.K., Li C., Lau C.C., Poon V.K., Chan C.C., et al. Leptin mediates the pathogenesis of severe influenza A(H1N1)pdm09 associated with cytokine dysregulation is preventable by anti-leptin antibody in diet-induced obese mice. JInfect Dis 2013.
141. Smith A.G., Sheridan P.A., Tseng R.J., Sheridan J.F., Beck M.A. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 2009, 126:268-279.
142. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity impairs the T cell memory response to influenza virus infection. JImmunol 2010, 184:3127-3133.
143. Karlsson E.A., Sheridan P.A., Beck M.A. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. JNutr 2010, 140:1691-1697.